Tachikawa, Japan

Minoru Hirano

This inventor holds 2 USPTO granted patents. Top assignees: Bristol-Myers Squibb, Bristol-Myers Squibb Compnay. Active years: 1994-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minoru Hirano. Retrieved from https://idiyas.com/inventor/minoru-hirano-bw9v3oq6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1994-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Minoru Hirano: Innovator in Antifungal Compounds

Introduction

Minoru Hirano is a notable inventor based in Tachikawa, Japan. He has made significant contributions to the field of antifungal compounds, holding a total of 2 patents. His work focuses on developing novel compounds that enhance the effectiveness of existing antifungal treatments.

Latest Patents

Hirano's latest patents involve the creation of pradimicin compounds. These compounds are disclosed as novel entities that possess antifungal activity and improved water solubility. The innovative aspect of these compounds lies in the modification of the 4'-amino or 4'-alkylamino moieties of known pradimicin compounds, which enhances their therapeutic potential.

Career Highlights

Throughout his career, Minoru Hirano has worked with prominent companies, including Bristol-Myers Squibb. His experience in the pharmaceutical industry has allowed him to contribute to the development of effective antifungal treatments.

Collaborations

Hirano has collaborated with esteemed colleagues such as Hajime Kamachi and Shinji Masuyoshi. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.

Conclusion

Minoru Hirano's contributions to the field of antifungal compounds through his innovative patents highlight his role as a significant inventor. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…